638 related articles for article (PubMed ID: 19155531)
1. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
[TBL] [Abstract][Full Text] [Related]
2. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
3. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
[TBL] [Abstract][Full Text] [Related]
4. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
5. Association of body mass index with decline in residual kidney function after initiation of dialysis.
Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
[TBL] [Abstract][Full Text] [Related]
6. Predictors of residual renal function loss in peritoneal dialysis: is previous renal transplantation a risk factor?
Bernardo A; Fonseca I; Rodrigues A; Carvalho MJ; Cabrita A
Adv Perit Dial; 2009; 25():110-4. PubMed ID: 19886330
[TBL] [Abstract][Full Text] [Related]
7. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
[TBL] [Abstract][Full Text] [Related]
8. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
[TBL] [Abstract][Full Text] [Related]
9. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
10. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
12. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients.
Noordzij M; Boeschoten EW; Bos WJ; Dekker FW; Bossuyt PM; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2007 Oct; 22(10):2944-9. PubMed ID: 17597087
[TBL] [Abstract][Full Text] [Related]
13. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
[TBL] [Abstract][Full Text] [Related]
14. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
[TBL] [Abstract][Full Text] [Related]
15. Loss of residual renal function in patients on peritoneal dialysis.
Lutes R; Perlmutter J; Holley JL; Bernardini J; Piraino B
Adv Perit Dial; 1993; 9():165-8. PubMed ID: 8105915
[TBL] [Abstract][Full Text] [Related]
16. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
[TBL] [Abstract][Full Text] [Related]
17. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
18. Effect of iodinated contrast agents on residual renal function in PD patients.
Moranne O; Willoteaux S; Pagniez D; Dequiedt P; Boulanger E
Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of furosemide in patients on peritoneal dialysis.
Flinn A; Ledger S; Blake P
CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
[TBL] [Abstract][Full Text] [Related]
20. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients.
Han SH; Lee SC; Ahn SV; Lee JE; Kim DK; Lee TH; Moon SJ; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
Nephrol Dial Transplant; 2007 Sep; 22(9):2653-8. PubMed ID: 17517797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]